Flow Chemistry Market Size Would Be $2.39 Billion By 2025 | CAGR: 9.9%: Grand View Research, Inc.

According to a report published by Grand View Research, Inc.; the global flow chemistry market is anticipated to reach a valuation of around USD 2.39 billion by 2024. High adoption in chemicals and pharmaceutical industries, growing focus on safety and cost effectiveness, and strict environmental regulations can propel the market over the forecast period (2014 to 2025). Several regulatory bodies like the European Commission and the U.S. Food and Drug Administration (FDA) are supporting the practice of flow chemistry for manufacturing chemicals and active pharmaceutical ingredients (APIs).
Increasing adoption of flow cytometry in pharmaceuticals is considered as the major driving factor for global market during the forecast period. The technology is environment-friendly and possesses superior properties compared to batch production processes. Flow chemistry is used in laboratory scale applications due to its high safety level during gas-based reactions. Its advantageous properties such as reduced reaction steps, low maintenance, and controlled environment can boost the adoption. Apart from that, high usage of gas-based flow chemistry technology is expected to create positive outlook for the market over the forecast period.

Flow chemistry is used along with photochemistry, microwave irradiation, electrochemistry, inductive heating, and 3D printing technologies to accomplish fully automated process with sustainability and high efficiency. Currently, 3D printing technology is used to produce reaction ware instruments for flow chemistry. It is helping to reduce manufacturing cost and improve the equipment strength. However, requirement of high investment to conduct research and development (R&D) activities may restrain the market growth over the forecast period.

The worldwide flow chemistry market can be segmented on the basis of application, reactor, and regions. Based on application, the market can be divided into academia and research, pharmaceuticals, chemicals, petrochemicals, and others. Petrochemicals may witness a CAGR of over 9% during the forecast period. This growth can be attributed to the highly favorable conditions for polyethylene and ethylene production in North America.

As per reactor, the market can be categorized into continuous stirred-tank reactor (CSTR), microwave system, microreactor, plug flow reactor, and others. The CSTR segment is likely to progress at a CAGR of over 8% from 2015 to 2025. High adoption of these reactors is attributed to their compatibility with liquid, gas, and solid-liquid reaction phases.

Geographically, the market for flow chemistry can be divided into North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. In 2015, North America accounted for the largest market share of around 36.8% in terms of revenue. This growth can be accredited to rapid technological advancements and the presence of a strong chemical manufacturing infrastructure. Additionally, high investments in petrochemical manufacturing is also anticipated to boost the regiona market during the forecast period.

In 2016, Europe held over 22.1% of total market share in terms of revenue. It is one of the fastest growing regions and has been witnessing augmented demand for flow reactors from chemical industry. The regional growth can be attributed to the rise in pharmaceutical manufacturing research and development activities in the UK, France, Switzerland, and Germany.

Asia Pacific, on the other hand, is likely to witness a CAGR of over 11% from 2016 to 2025. This growth can be attributed to the growing investment in chemical and pharmaceutical manufacturing in the region. Increasing preference for green and energy-efficient technology is expected to propel the utilization of flow reactors in the region. The pharmaceutical market is likely to showcase substantial growth in countries such as China, India, Vietnam, Sri Lanka, Bangladesh, and Myanmar. All these factors may further impel the regional market for flow chemistry.

In 2015, Middle East and Africa (MEA) held the lowest market share in terms of revenue. The petrochemical industry is anticipated to exhibit rapid growth over the forecast period due to the existence of key manufacturers. The region is one of the major exporter of petrochemicals to Europe and. This may create business opportunities in the forthcoming years.

Major players operating in the flow chemistry market include ThalesNano Inc.; PDC Machines Inc.; Saida FDS Inc.; Little thing factory GmbH; and Vapourtec Ltd. Most companies are making high investment in R&D to discover instruments that can help to optimize production process and improve the efficiency. Increasing demand for specialty chemicals across the world has also helped manufacturers to form associations with end-users. Market participants are also tying up with educational institutions to take advantage from their inhouse R&D facilities to develop advanced technologies.


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Ethoxylates Market Total Revenue Would Be $14.75 Billion By 2025 | CAGR: 3.5%: Grand View Research, Inc.

According to a research report by Grand View Research, Inc.; the global ethoxylates market is projected to reach a valuation of around USD 14.75 billion by 2025. The marker is expected to register a healthy growth rate of nearly 3.5% during the forecast period i.e., from 2017 to 2025. This growth is attributed to the rising demand from personal care products and detergents due to exceptional cleansing properties of ethoxylates. In addition, extensive usage of ethoxylates as an ingredient in emulsions and ointments in the pharmaceuticals sector is also anticipated to drive the growth over the next few years. Moreover, high demand for ethoxylates-based insecticides and herbicides to enhance the crop yield is also expected to contribute toward expansion of the global market.

Furthermore, rapid technological developments in the field of metal manufacturing is projected to result in an increased demand for ethoxylates as a constituent of the metal working fluid formulations for foam control. The growing product demand in industrial applications as a wetting agent is also expected to drive the development of the global market. Various properties of ethoxylates such as low rinse, high oxidation resistance, and superior de-emulsification have enabled its usage in petroleum refining. This factor is likely to have a positive impact on the growth of the global market over the next few years.


The global ethoxylates market is categorized on the basis of product type, end use, application, and region. On the basis of product type, the market is further divided into fatty amine ethoxylates, alcohol ethoxylates, glyceride ethoxylates, ethyl ester ethoxylates, fatty acid ethoxylates, and others. On the basis of end use, the market is divided into personal care products, foam control and wetting agents, detergents, insecticides, herbicides, lubricants and emulsifiers, emulsions and ointment, and others.

On the basis of application, the market for ethoxylates is segregated into pharmaceutical, oilfield chemicals, household and personal care, agrochemicals, institutional and industrial cleaning, and others. The pharmaceuticals segment is projected to reach a valuation of around USD 909.0 million by 2025. This growth can be attributed to the rising usage of ethoxylates for better quality emulsifiers for the production of emulsions and ointments. On the basis of geographies, the market is divided into Europe, North America, Central and South America, Middle East and Africa (MEA), and Asia Pacific.

The North America regional market is anticipated to have a sustainable development during the forecast period as a result of an extensive usage of personal care products by consumers in this region. In addition, high disposable income of the consumers and the rising willingness to spend on household cleaning and personal care products are also projected to have a major impact on the regional growth. Moreover, highly supportive regulations by the Food and Drug Administration (FDA) regarding the product usage is also expected to boost the ethoxylates market growth in near future.

The Asia Pacific region accounted for around 31.1% of the overall market share on account of high product consumption in various nations, particularly in Australia, India, China, and Japan. The region is anticipated to witness the maximum growth over the forecast years due to the presence of emerging economies such as China, India, South Korea, and Japan. In addition, rapidly expanding manufacturing plants of various cleansing products due to availability of low-cost labor is also said to fuel the market growth in this region. Furthermore, escalating demand for ethoxylates due to the growing consumer sector in India and China is also likely to spur regional market development over the forecast period.

The major companies operating in the global ethoxylates market include E.I. du Pont de Nemours and Company; INEOS Group Holding S.A.; Huntsman International LLC; Evonik Industries AG; Mitsui Chemicals, Inc.; and Royal Dutch Shell PLC. Most of the pioneers in this field focus on product and technology development in order to expand their business and global presence.


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Diabetes Devices Market Size Would Be $35.5 Billion By 2024 | CAGR 7.0%: Grand View Research, Inc.

The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.

Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.
Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/diabetes-devices-market

Further key findings from the study suggest:
  • Constantly rising target population base is the primary factor driving market growth
  • Test strips capturedthe largest share in the monitoring and diagnostics device segment while insulin pens accounted for the largest revenue share among insulin delivery devices in 2016. This can be attributed to rapid adoption of these user-friendly, quick, and accurate devices for homecare use
  • North America is leading the regional market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products have driven the regional market
  • Key players in the market include Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.
Grand View Research has segmented the global diabetes devices market on the basis of product type and region:
Diabetes Devices Product Type Outlook (Revenue, USD Million, 2014 - 2024)
  • Monitoring and Diagnostic Devices
    • Lancets
    • Analog Glucose Monitor
    • Continuous Glucose Monitor
    • Test Strips
  • Insulin Delivery Devices
    • Syringe
    • Pens
    • Pumps
    • Injectors
Diabetes Devices Regional Outlook (Revenue, USD Million, 2014 - 2024)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Construction Flooring Chemical Market Is Poised To Reach $6.15 Billion By 2025: Grand View Research, Inc.

The global construction flooring chemicals market is projected to reach approximately USD 6.15 billion by 2025, growing at a CAGR of 4.7% during forecast period, according to a new report published by Grand View Research, Inc. Increasing growth of millennials and nuclear families as well as rise in disposable income towards capability in purchasing of residential apartments in emerging markets is expected to promote the usage of flooring chemicals. Also, the growth of manufacturing facilities in developing nations is projected to increase the application of construction flooring chemicals over the forecast period. 

Flooring chemicals demand in the commercial sector is expected to grow at a CAGR of 3.8% in terms of volume from 2016 to 2025. The lucrative manufacturing outlook in developing nations including China and India on account of easy availability of chemical feedstock and cheap labor is expected to result in establishment of new commercial spaces. Above mentioned favorable trend toward the formation of new strategic business units (SBUs) is expected to increase the application of flooring and thus in turn will have a positive impact on market.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/construction-flooring-chemicals-market

Further key findings from the report suggest:
  • Demand for construction flooring chemicals in North America will surge in accordance with growth in renovation and occupancy of building in prime locations such as San Francisco and New York. construction flooring chemicals market is expected to witness a CAGR of 2.3% in terms of revenue. Mature market such as U.S. have expanding client request, greater interest in terms of renovations, as well as implementation of designs.
  • MEA construction flooring chemicals market is expected to witness revenue growth at a CAGR of 4.9% from 2017 to 2025. This growth in attributed to the increasing penetration of corporate offices, retail outlets as well as luxury hotels in UAE and Saudi Arabia.
  • Epoxy resins is set to witness a CAGR of 4.5% from 2017 to 2025 in terms of revenue in MEA region, on account of its application in construction of luxury residences, hotels, resorts and urban corporate offices.
  • Key vendors include BASF, SABIC, DOW chemicals,Sinopec., ExxonMobil, DuPont, Ineos,LyondellBasell Industries, Mitsubishi Chemical Corporation, LG Chem, AkzoNobel, Mitsui Chemicals, Forbo Holding, Toray Industries., PPG Industries, Tremco Inc, RPM International Inc, Stonhard Inc, Huntsman Corp and Borealis.AG
  • In June 2016, Dow Chemical Company completed the strategic ownership of Dow Corning and its silicone business. The ownership is likely to improve new chemistry and enhance existing technology to Dow as well as extending its participation in Consumer, Infrastructure, transportation, packaging and electronics. Dow Corning will operate as a wholly owned subsidiary of Dow, and will be headquartered with Dow in Midland, Michigan.
Grand View Research has segmented the construction flooring chemicals market on the basis of product and application:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)
  • Epoxy
  • Vinyl
  • Polyurethanes
  • Poly Methyl Methacrylate (PMMA)
  • Others
Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)
  • Residential
  • Commercial
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)
  • North America
    • US.
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa (MEA)
    • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Clinical Microbiology Market Is Poised To Reach $16.7 Billion By 2025: Grand View Research, Inc.

The global clinical microbiology market size is expected to reach USD 16.7 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.


In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/clinical-microbiology-market

Further key findings from the study suggest:
  • Owing to rapid adoption of technology and automation of work flow, laboratory instruments are expected to form the fastest growing segment over the forecast period
  • Reagents captured the largest revenue share in 2016 owing to repeat purchase of reagents
  • In 2015, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid
  • The clinical microbiology market is presently dominated by a few key participants such as bioMerieux S.A.; Cepheid Inc.; Danaher Corporation; and Bruker Corporation
  • Other prominent players operating in the market include Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc.
Grand View Research has segmented the global clinical microbiology market on the basis of product, application, and region:

Clinical Microbiology Product Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Laboratory Instruments
    • Incubators
    • Gram Stainers
    • Bacterial Colony Counters
    • Autoclave Sterilizers
    • Petri Dish Fillers
    • Automated Culture Systems
  • Microbiology Analyzers
    • Molecular Diagnostic Instruments
    • Microscopes
    • Mass Spectrometers
  • Reagents
Clinical Microbiology Application Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other Diseases
Clinical Microbiology Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

PoE Chipsets Market Is Predicted To Exceed $1.22 Billion by 2025 | CAGR: 12.6%: Grand View Research, Inc.

The global Power over Ethernet chipsets market size is likely to reach USD 1.22 billion by 2025, according to a new report by Grand View Research, progressing at a CAGR of 12.6% during the forecast period. Increasing applications of Power over Ethernet (PoE) chipsets in the residential sector, for instance, in IP telephones, webcams & closed-circuit televisions (CCTVs), and complete wireless local area network (WLAN) coverage are poised to stoke the growth of the market over the forecast period.

Key benefit of Power over Ethernet is that it is able to transmit both network connectivity as well as power supply over a single cable and overcomes the need for installing separate wires. Similarly, VoIP phones allow transmission of mobile signal over a data network. Rising awareness regarding these merits is projected to support the growth of the market.

Growing IT developments in the education and healthcare sectors are leading to an increase in deployment of the PoE chipset technology in the commercial sector. Enhanced applications of technology such as smart meters use the Ethernet technology for benefits such as energy efficiency, improved comfort, convenience, and security. Increasing number of installations of smart meters is anticipated to drive the Power over Ethernet market over the forecast period. Surging demand for better network access and minimum disruption and cost is leading to an increase in installations of PoE chipsets in various businesses.

North America accounted for the largest share in the market in 2017. The Asia Pacific regional market is estimated to witness tread along a healthy growth track over the forecast period, on account of growing demand for high-speed internet facilities and automation across different industries. Additionally, Japan, China, India, Singapore, and Hong Kong are expected to be the key contributors to the growth for the upcoming 802.3bt standard in the region. 

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/power-over-ethernet-poe-chipsets-market

Further key findings from the report suggest:
  • Demand for Power over Ethernet chipsets is expected to increase owing to growing penetration of internet in developing nations.
  • The Power Sourcing Equipment (PSE) segment is estimated to post a CAGR of 11.7% over the forecast period
  • The U.S., China, and Japan are anticipated to witness considerable growth over the forecast period, owing to favorable regulations
  • The key players in the PoE chipsets market include Akros Silicon, Inc.; Cisco Systems, Inc.; Flexcomm Technology Limited; Maxim Integrated Products, Inc.; Microsemi Corporation; Texas Instruments Incorporated; Linear Technology Corporation; ON Semiconductor; Silicon Laboratories; and STMicroelectronics.
Grand View Research has segmented the PoE chipset market report on the basis of type, standard, end-use, and region:

Type Outlook (Revenue, USD Million; 2014 - 2025)
  • PoE Power Sourcing Equipment (PSE) Chipset
  • PoE Powered Devices (PD) Chipset
Standard Outlook (Revenue, USD Million; 2014 - 2025)
  • 3af standard
  • 3at standard
  • 3bt standard
Application (Revenue, USD Million; 2014 - 2025)
  • Connectivity
  • Infotainment
  • LED Lighting
  • Security
  • Others
End User Outlook (Revenue, USD Million; 2014 - 2025)
  • Commercial
    • Office Buildings and Small Offices
    • Retail
    • Healthcare
    • Hospitality
  • Industrial
  • Residential
Device Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Network Cameras
  • VoIP Phone
  • Ethernet Switch & Injector
  • Wireless Radio Access Point
  • Proximity Sensor
  • Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • South America
    • Brazil
  • MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hernia Mesh Devices Market Is Estimated To Touch $199.6 Million By 2025: Grand View Research, Inc.

The global hernia mesh devices market is expected to reach USD 199.6 million by 2025, based on a new report by Grand View Research, Inc. The market is expected to grow over the forecast period owing to increase in incidence of hernia, high adoption of meshes in surgeries due to factors such as cost-effectiveness, reduced pain, reduced operative time, and high availability of products in the market. 

The reimbursement scenario for hernia mesh is favorable, which encourages patients to opt for open or laparoscopic surgery. Patients have easy access to detailed reimbursement codes and ratios, which are made available by government and industry players. The codes are granulated to types of hernias, (primary or recurrent) and method of surgery (open or laparoscopic).

Furthermore, technological advancements and new products introduction, such as TELA Bio, are driving the overall market growth. In 2010, PROCEED Ventral Patch (PVP) device was launched by Ethicon for the treatment of umbilical hernia. In 2016, GORE SYNECOR biomaterial, a product of W. L. Gore & Associates, was approved by FDA as a repair solution for ventral hernia. 

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/hernia-mesh-devices-market

Further Key Findings from the Study Suggest:
  • Biological surgical meshes is the fastest growing segment owing to high price of the products and increased preference for these products by healthcare professionals and patients
  • In February 2016, an EU-funded Green Nano Mesh was launched for bio-based, eco-friendly treatment of hernia that would cause less harm to patients
  • Geographically, North America held the largest market share in 2016 and is expected to maintain its position during the forecast period. Factors responsible for the large market share are high incidence of the target disorder and high adoption of surgical meshes as a treatment option
  • Asia Pacific is also expected to witness rapid growth over the forecast period. Growing awareness about the target disorder and improved access to healthcare drives the growth in this region
  • The 13th International Congress of Asia Pacific Hernia Society is intended to be held in China in September 2017
  • Some of the key players in the hernia mesh market are Medtronic; Ethicon, Inc., C. R. Bard, Inc.; Atrium Medical; and B. Braun Melsungen AG.
Grand View Research has segmented the hernia mesh devices market by hernia type, mesh type and region:
Hernia Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Inguinal Hernia
  • Incisional Hernia
  • Femoral Hernia
  • Others
Mesh Type Outlook (Market Revenue in USD Million, 2014 - 2025)
  • Biologic Mesh
  • Synthetic Mesh
Regional Outlook (Market Revenue in USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gynecological Devices Market Revenue Will Be Approx. $20.6 Billion By 2022

A report published by Grand View Research, Inc. suggests that the global gynecological device market would reach nearly USD 20.6 billion by 2022. The market would grow at around CAGR of 15.6% during the forecast period (from 2017 to 2022). Increasing target population base across the globe along with the rising awareness regarding early diagnosis and availability of treatments can drive the global market. Furthermore, rising adoption of gynecological procedures due to high prevalence of gynecological diseases such as polycystic ovary syndrome or PCOS, cervical cancer, uterine cancer, and other conditions is also likely to spur the market expansion over the coming years. For example, according to the report by the Disease Control and Prevention (CDC), the number of obstetrical treatments performed in 2014 was more than 7.3 million in the United States alone.

In addition, rising occurrences of sexually Transmitted Diseases or STDs have also resulted in an increased demand for gynecological treatments. On the other hand, strict regulatory approval procedures to ensure safety may have a negative impact on the global gynecological device market during the forecast period. Additionally, improved drug therapy and rapid development of alternative therapies like personalized medicines are also restraining the market growth. However, the advent of technologically advanced devices that help increase the efficiency of minimally invasive surgeries along with the development of advanced imaging devices like 3D endoscope is likely to propel the market expansion. Moreover, rising number of C-section surgeries due to various health issues caused by changing lifestyles is also likely to contribute toward the development of the gynecological device market in coming years.


The global gynecological device market is categorized on the basis of product type and regions. Based on product type, the market is fragmented into endometrial ablation devices such as radiofrequency ablation devices, surgical devices (gynecological endoscopy devices such as Hysteroscope), female sterilization or contraceptive devices such as temporary or permanent birth control, fluid management systems, diagnostic imaging systems, and hand instruments such as disposable and reusable biopsy forceps. On the basis of geographies, the market is divided into Latin America, Middle East and Africa (MEA), North America, Asia Pacific, and Europe.

The North America region is anticipated to continue leading the global market for gynecological devices during the forecast years. Quick adoption of advanced technologies in the field of gynecology along with the availability of skilled professionals are the key factor driving the regional growth. The presence of highly sophisticated healthcare infrastructure across the region is likely to spur the regional market expansion. Positive reimbursement coverage policies by various government bodies and private firms are also projected to augment the regional market in the years to come.

The Asia Pacific regional gynecological devices market is anticipated to expand at around 10.6% CAGR from 2017 to 2022. India and China, being the world’s highly populated nations, are expected to create numerous growth opportunities for the market in near future. Increasing number of gynecological surgeries, mainly due to the rapidly expanding medical tourism in the region is also expected to drive the market in the forthcoming years. Various initiatives by regional governments for population control, such as awareness drives regarding availability of gynecological treatments and overall women’s health have resulted in an increased demand for contraceptive measures. This factor is also likely to spur the regional market development over the forecast period.

However, countries such as Vietnam and Bangladesh still have a high prevalence of sexually transmitted diseases, especially among young population base. The lack of easy access to contraceptive measures and awareness regarding disease prevention are the major contributing factors for this high prevalence of STDs in the region. This factor is also said to have a positive impact on the growth of the Asia Pacific gynecological devices market in the forthcoming years.

The major companies operating in the global market for gynecological devices include Boston Scientific Corp.; Karl Storz GmbH & Co. KG; Richard Wolf GmbH; Hologic, Inc.; and Medtronic Public Limited Company.


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Geographic Information System Market Size Would Be $11.2 billion by 2025: Grand View Research, Inc.

The global geographic information system (GIS) market is anticipated to reach USD 11.2 billion by 2025, according to a new report by Grand View Research, Inc. The rising adoption of GIS in infrastructure development, urban planning, and smart cities coupled with increasing location-based services are some of the key drivers of the GIS market.

GIS is a computerized system that connects data with geography. Several decisions are taken using GIS, right from tracking a store location to predicting climate change and analyzing a crime pattern. GIS helps users to link the data with geographic location to gain spatial insights from the extracted data.

The growing integration of GIS with conventional technologies has enhanced the business intelligence of companies. Moreover, the integration of GIS with IoT devices provides accurate data to users using the geospatial data analysis. For instance, an IoT-enabled valve can be monitored from anywhere around the globe using geospatial data.

The demand for location-based services, such as real-time status and control of a valve, have been on a rising curve around the globe. The market for GIS is expected to grow over the forecast period owing to technological advancements and growing applications. Moreover, the growing awareness among private companies regarding benefits such as improved productivity and optimization of processes offered by GIS has resulted in the technology’s increased demand.

Organizations in the private sector use the geographic information system for applications such as mining, oil & gas, transportation & logistics, and defense equipment, among others. The rising application of geographic information systems in construction is anticipated to, in turn, boost the market demand over the forecast period.

To request a sample copy or view summary of this report, click the link below: 

Further key findings from the report suggest:
  • The growing adoption of GIS in surveying and mapping by several regions is anticipated to drive the market growth.
  • The construction segment is expected to register a high CAGR of 11.2% over the projected period.
  • The Asia Pacific regional market is expected to witness significant growth over the forecast period, owing to the large-scale penetration of GIS.
  • Key players in the market include Autodesk Inc.,The Economic and Social Research Institute (ESRI), Hexagon AB, and Pitney Bowes Inc.
Grand View Research has segmented the GIS market based on components, usage, applications, devices, and regions:
Components Outlook (Revenue, USD Million; 2014 - 2025)
  • Hardware
  • Software
  • Services
Usage Outlook (Revenue, USD Million; 2014 - 2025)
  • Surveying
  • Mapping
  • Navigation
Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Transport and Logistics
  • Agriculture
  • Construction
  • Mining and Geology
  • Oil & Gas
  • Aerospace and Defense
  • Utilities
  • Government
Device Outlook (Revenue, USD Million; 2014 - 2025)
  • Desktop
  • Mobile
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • South America
    • Brazil
  • Middle East and Africa
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Gas Turbine Service Market Is Poised To Reach $41.6 Billion By 2025 | CAGR 8.5%: Grand View Research, Inc.

The global Gas Turbine Service Market size is expected to reach USD 41.6 billion by 2025, according to a new report by Grand View Research, Inc. The global market is anticipated to register a CAGR of 8.5% during the forecast period. Availability of natural gas in large quantities coupled with its relatively lower prices, especially in North America, China, and Thailand, has led to an increase in power generation using gas turbines. 

The standby inspection (consist servicing of the relays cleaning, battery system, checking oil & water level and device calibration), running inspection, and combustion inspection (includes inspection of fuel nozzles and combustion liners) are the major maintenance and repair activities which are performed at different time interval, depending upon various factors such as operating hours, geographical condition, fuel, etc.

Growing focus on generating electricity through cleaner sources and discouragement of utilizing coal reserves are the factors anticipated to increase the share of gas turbines in the global energy mix. This, in turn, is expected to provide a favorable environment for the development of this market. One such strategy includes the recent orders passed by the current U.S. government to reverse the energy policies of the previous government and stop the war on coal, which is expected to boost the use of natural gas for energy production over the forecast period.

According to Diesel & Gas Turbine Worldwide, the total number of industrial gas turbines ordered in 2014 were 569 units, which increased to 581 in 2016. Of these, the total number of natural gas-fired industrial turbines, ranging from 30 MW to 120 MW, were 62 units in 2014 and reached 147 in 2016. Growth in industrial turbine installations across the globe is creating more opportunities for aftermarket services, which is building a favorable environment for the growth of gas turbine maintenance market.

Throughout their lifespan, the turbines undergo various inspections at different intervals. Combustor inspection (at 8,000-12,000 EOH), hot gas path inspection (at 24,000-50,000 EOH), and major inspection/overhaul (at 48,000-70,000 EOH) are some of the critical inspections that are essential for the reliable operation of gas turbines. Increasing utilization of gas turbines in resource extraction, processing applications, manufacturing facilities, and packaging plants is widening the product application scope, which is also projected to boost the aftermarket services for gas turbines. Increasing demand for the aftermarket services for gas turbine is projected to provide a substantial growth potential to the gas turbine service market.

Technological development in data collection methods is enabling players in this industry to form a constitutive model for materials. Test rig control helps in gathering and analyzing large volumes of data, thereby allowing players to create the most suitable maintenance plan and models for gas turbines.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/gas-turbine-services-market

Further key findings from the report suggest:
  • The global gas turbine service market was valued at USD 23.9 billion in 2017. The market is projected to witness a CAGR of 8.5% during the forecast period
  • The industry is highly consolidated in nature and is centered around five major players, which hold over 60% of the market
  • Early defect detection through the use of software and the preventive maintenance results in substantial cost saving, which has increased the importance of service providers in gas turbine market
  • Ease of maintenance and operation, higher efficiency, relatively lesser weight, and compatibility at offshore locations are some significant factors projected to drive the demand for <100 MW turbines
  • The key players include GE Power, Siemens AG, Mitsubishi Hitachi Power Systems, Ltd. (MHPS), Kawasaki Heavy Industries, Ltd., and MAN Diesel & Turbo SE.
Grand View Research has segmented the global gas turbine service market on the basis of turbine type, turbine capacity, service type, service provider, end use, and region:
Gas Turbine Service Turbine Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Heavy Duty
  • Industrial
  • Aeroderivatives
Gas Turbine Service Turbine Capacity Outlook (Revenue, USD Million, 2014 - 2025)
  • <100 MW
  • 100 to 200 MW
  • >200 MW
Gas Turbine Service Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Maintenance & Repair
  • Overhaul
  • Spare Parts Supply
Gas Turbine Service Provider Outlook (Revenue, USD Million, 2014 - 2025)
  • OEM
  • Non-OEM
Gas Turbine Service End-use Outlook (Revenue, USD Million, 2014 - 2025)
  • Power Generation
  • Oil & Gas
  • Other Industrial
Gas Turbine Service Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • Indonesia
    • Malaysia
    • Vietnam
    • Bangladesh
    • Pakistan
    • Singapore
    • Thailand
  • The Commonwealth of Independent States (CIS)
    • Azerbaijan
    • Kazakhstan
    • Russia
    • Turkey
    • Turkmenistan
    • Ukraine
    • Uzbekistan
  • Central & South America
    • Brazil
  • Middle East & Africa
    • UAE
    • Oman
    • Iraq
    • Qatar
    • Lebanon
    • Algeria
    • Tunisia
    • Kuwait
    • Ghana
    • South Africa
 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Food Robotics Market Total Size In Terms Of Revenue Would Be $3.35 Billion By 2025 | CAGR: 13.1%

According to a report by Grand View Research, Inc., global food robotics market is estimated to reach at USD 3.35 billion by 2025 growing at a CAGR of 13.1% over the forecast period (from 2018 to 2025). Growing requirement for high operational efficiency in production process, as a result of increasing need for packaged and processed foods, is anticipated to propel the demand for food robotics. Automated machines offer maximum work efficiency at reduced labor cost. Continuous technological developments in robotics coupled with introduction of advanced and innovative automation technologies can further stimulate the demand for robotic systems. In addition, stringent government regulations for food safety are also anticipated to contribute toward the market growth.

The food robotics market is segregated on the basis of product type, payload, application, and region. Based on product type, the market is classified into parallel, articulated, SCARA, cylindrical, and other. In 2016, articulated segment dominated the market and accounted for the highest market share. The SCARA, parallel, and cylindrical segments are expected to have a substantial growth during the forecast period. Based on payload, the market can be divided into medium, low, and heavy. Low and medium payload capacity segments are anticipated to grow rapidly during the forecast period. Low, medium, and heavy payload systems can have payload capacities of 0–10 kg, 10 kg–100 kg, and 100+ kg, respectively.


Based on application, the market is segregated into repackaging, packaging, palletizing, picking, processing, other. Packaging segment is expected to grow at phenomenal CAGR during the forecast period mainly due to rising demand for packaged food. Growing adoption of automated machines in food processing is also estimated to drive the processing and repackaging segments over the forecast period. Based on geographies, the market is divided into Europe, North America, Asia Pacific, and Rest of the World (ROW). In 2016, Europe dominated the global market and accounted for the largest share attributed to strict food safety regulations and increasing labor costs. Regulatory measures taken by the European governments towards food safety are also likely to impel the demand for automated systems in the region.

In Asia Pacific, the market is anticipated to witness a remarkable growth during the forecast period. High demand for packaged and processed food owing to increasing disposable income has fueled the adoption of food automation technologies in the region. In North America, the market is expected to grow substantially over the next few years. Strong presence of prominent manufacturers is expected to be the key factor driving the market growth in this region.

Some of the leading companies offering food robotics are Yaskawa Electric Corporation; ABB Group; Kawasaki Heavy Industries Ltd.; Fanuc Corporation; and Mitsubishi Electric Industries. Most of the companies invest in R&D to introduce advanced robotic solutions to meet rising consumer demands. For instance, Japanese electronics giant Sony and Carnegie Mellon University (CMU) have collaborated for a research study on use of robotics and Artificial Intelligence (AI) to optimize food preparation, cooking, and delivery. Research work is expected to be carried out at the CMU’s School of Computer Science in Pittsburg. The team includes experts from various fields such as Machine Learning (ML), AI, and robotics. The team will be developing robots that can handle irregular and fragile materials to perform small or even complex commercial and household tasks.


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Single Cell Analysis Market Is Predicted To Outshine $5.9 Billion By 2025 | CAGR 17.3%

The global Single Cell Analysis Market size is expected to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 17.3% during the forecast period. High demand for early detection techniques and rapid technological advancements are creating a significant demand for single cell analysis. This technique is used in genomic, transcriptomic, proteomics, and epigenetic studies.

Single cell analytics helps assess cellular heterogeneity and aids in analysis of pathways and processes at a molecular level. It can be performed with samples as small as a single cell. Its current applications in diagnostics include genetic analysis, prenatal screening, cancer genomics, and neurological therapeutics.

Rising prevalence of chronic diseases is anticipated to drive demand for molecular assay services, subsequently leading to the growth of this sector. Single cell analysis plays an important role in risk management related to organ transplants, cancer, heart failure, renal diseases, and infectious disease testing by performing fast, accurate, and effective tests.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/single-cell-analysis-market

Further key findings from the study suggest:
  • In 2016, consumables accounted for the largest market share owing to rapid adoption of beads and microplates, repeat purchase of reagents, and demand for assay kits
  • Automated instruments lead the instruments segment, owing to their advantages over manually operated variants
  • Companies in this market are implementing strategies such as mergers and acquisitions to expand their product portfolio and to strengthen their position. The partnership between Illumina, Inc. and Bio-Rad Laboratories, Inc. is an example of strategies implemented by leading players
  • Major players in this market include, but are not limited to, Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Merck Millipore GmbH; Beckman Coulter, Inc. (U.S.); and Becton, Dickinson and Company (U.S.).
Grand View Research has segmented the global single cell analysis market on the basis of product, application, and region:

Single Cell Analysis Product Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Consumables
    • Reagents
    • Assay Kits
    • Other Consumables
  • Instruments
    • Manual Instruments
    • Microscopes
    • Haemocytometers
    • Automated Instruments
    • Flowcytometers
    • Next Generation Sequencing
    • PCR Systems
    • High-content Screening System
    • Cell Microarrays
    • Automated Cell Counters
Single Cell Analysis Application Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Non-invasive Prenatal Diagnosis
  • In-vitro Fertilization
Single Cell Analysis Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • South Africa
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Lactoferrin Market Would Be $167.9 Million By 2025 | CAGR: 8.4%: Grand View Research, Inc.

The global lactoferrin market is expected to reach USD 167.9 million by 2025, according to a new report by Grand View Research, Inc. Increasing demand for infant formula has been a major factor driving market growth. Utilization of lactoferrin has increased owing to the rising health concerns among consumers.

Lactoferrin is derived from the transferrin family and is a multifunctional protein. Transferrins are glycoproteins and are known to have the ability to control the free iron content in the human body, and bind them together. The transferrin family derivative is present in extensive quantities in various parts of the human body including, tears, nasal secretions, milk, and saliva.

The multifunctional protein helps to separate the free iron in the human body and also remove any content which promotes bacterial activity. The transferring family derivative helps to inhibit the bacterial growth by binding the lipopolysaccharides with bacterial walls and thus forming peroxides. Owing to this ability of the multifunctional protein, it is widely used in the healthcare sector for curing and preventing bacterial infections & diseases. The antibacterial function of lactoferrin is projected to show a high growth over the next eight years. The antibacterial function segment had a market share of 20.4% in 2016.

Infant formula application segment is expected to have a steady growth rate over the next eight years with an estimated CAGR of 8.1%. The multifunctional protein is the key component of human milk required for infants as they help in iron absorption and its transportation. Cow’s milk contains the multifunctional protein in minute quantities of 0.1 mg/mL, whereas infants require it in the quantities of 2-3 mg/mL. Commercially produced infant formula with lactoferrin content has high iron absorption, antibacterial, and antioxidation properties. This factor is projected to propel the infant formula segment growth over the next eight years.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/lactoferrin-market

Further key findings from the report suggest:
  • The global lactoferrin demand was 255.0 tons in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
  • Iron absorption emerged as the largest function segment in 2016 and is estimated to be worth 151.9 tons by 2025
  • Intestinal flora protection is anticipated to be the fastest growing function segment over the next eight years and is estimated to grow at a CAGR of 8.7%
  • The global lactoferrin demand in food & beverages application was valued at USD 19.7 million in 2016 and is anticipated to witness steady growth over the next eight years
  • Industry participants include Metagenics, Pharming Group N.V., Vitalus Nutrition Inc., Ingredia SA., MP Biomedicals, Glanbia Nutritionals, Farbest Brands, Fonterra Co-Operative Group Ltd., and ProHealth
Grand View Research has segmented the global lactoferrin market on the basis of function, application, and region:

Lactoferrin Function Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
  • Iron absorption
  • Anti-inflammatory
  • Intestinal flora protection
  • Antibacterial
  • Immune cell stimulation
  • Antioxidant
Lactoferrin Application Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
  • Food & beverages
  • Infant formula
  • Sports & functional food
  • Animal feed
  • Pharmaceuticals
  • Personal care products
Lactoferrin Regional Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)
  • North America
    • US.
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • Japan
  • Central & South America
  • Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Intelligent Transportation System Market Size Projected To Reach $66.5 Billion By 2024

The global intelligent transportation system (ITS) market is expected to reach USD 66.5 billion by 2024, according to a new report by Grand View Research, Inc. The usage of ITS to reduce road accidents and increase safety is a major driving force for the ITS market.

Demand for Vehicle-to-Vehicle (V2V) and Vehicle-to-Infrastructure (V2I) communication in order to enhance road safety is expected to gain momentum over the forecast period. The continuous progression and development have become a crucial need for betterment of road networks in the transportation systems. Enhancement in vehicle transport technology such as blind spot detection and electronic toll collection has continued to redefine the current opportunity and future prospects of sustainable traffic and transport management.

Additionally, congestion cost is a major issue for any nation in terms of fuel consumption and travel time. ITS and connected car technology is transforming mobility and safety on highways by avoiding crashes and reducing fatalities. As a result, there is a strong focus on deployment of advanced traffic systems and reducing the number of road accidents, which can be facilitated through ITS solutions.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/intelligent-transportation-systems-industry

Further key findings from the report suggest:
  • The ATMS is expected to remain the largest segment owing to the rising need to access real-time information captured by cameras and sensors. This system allows transport agencies to enable safe traveling by identifying and responding rapidly to the emergencies with real-time decision support tools.
  • Traffic management application is expected to grow at a CAGR of 12.1% from 2016 to 2024. Growing needs to minimize traffic congestion and pollution levels are boosting the need for traffic management solutions.
  • The North America ITS industry is anticipated to reach USD 26.29 billion by 2024. Increased government focus on passenger safety and implementation of traffic management projects and initiatives are propelling the demand for intelligent transportation system.
  • Asia Pacific is anticipated to be the fastest-growing region, growing at a CAGR of over 15.7% from 2016 to 2024. Increasing deployment of these systems propelled by the robust telecom and IT infrastructure has minimize transport-related issues in economy such as India.
  • Key players in the intelligent transportation system market include Kapsch TrafficCom AG, Iteris Inc., Thales Group, TomTom NV, Garmin International Inc. and Q-Free ASA. Companies are focusing on providing fully integrated safety solutions to develop technologies in the transportation infrastructure space.
Grand View Research has segmented the intelligent transportation system market on the basis of type, application and region:

ITS Type Outlook (Revenue, USD Million, 2014 - 2024)
  • ATIS
  • ATMS
  • ATPS
  • APTS
  • Cooperative vehicle system
ITS Application Outlook (Revenue, USD Million, 2014 - 2024)
  • Traffic management
  • Road safety and security
  • Freight management
  • Public transport
  • Environment protection
  • Automotive telematics
  • Parking management
  • Road user charging
ITS Regional Outlook (Revenue, USD Million, 2014 - 2024)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK.
  • Asia Pacific
    • China’
    • India
    • Japan
  • RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

Hemophilia Market Is Likely To Reach $15.2 Billion By 2024: Grand View Research, Inc.

The global hemophilia market valuation is anticipated to reach USD 15.2 billion by 2025, according to a report by Grand View Research, Inc. The market was valued at USD 9.86 billion in 2016 and expects to expand at around 5.6% CAGR from 2013 to 2024 (forecast period). According to a report by the World Federation of Hemophilia (WFH), only 30% to 40% individuals have undergone blood testing in 2013. Nearly 400,000 people were diagnosed with hemophilia in the same year. High probability of diagnostic procedures to discern blood-related disorders and appropriate measures for their treatment can drive market growth in near future.

Rising need for rapid diagnosis of hemophilia and government programs to assist in diagnosis are projected to augur the hemophilia market. Efforts by notable organizations such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Healthy Newborn Network (HNN) can further boost the market. An upsurge in the neonatal populace can positively drive the market development during the forecast period.


Mandatory screening procedures for hemophilia in neonates can bode well for the market for hemophilia. In addition, introduction of co-pay assistance programs made with cooperation of industry players to alleviate financial costs of tests are other factors expected to influence the market in the forthcoming years. For instance, Grifols S.A., an European company, has announced the launch of “ALPHANATE Copay Program” and “AlphaNine SD Copay Card” for immediate enrolment of patients opting for prophylaxis treatment.

Availability of limited therapies and enormous pressure on regulatory agencies to offer treatment options for royal blood diseases can increase the R&D expenditure for these diseases. Performance and efficacy of existing treatments and initiatives to commercially adopt prophylaxis treatment can also bode well for the market during the forecast period.

The worldwide hemophilia market is segmented by type, treatment, therapy, and region. By type, the market is divided into hemophilia A, B, C, and others. The hemophilia B segment is expected to exhibit a 6% CAGR over the forecast period owing to incidence of hemophilia B and emphasis on development of pipeline drugs to treat the disease. The hemophilia A segment can experience limited growth in near future due to an array of drugs already present in the market in addition to its high prevalence around the world.
By treatment, the market is bifurcated into prophylaxis and on-demand. The on-demand segment is expected to dominate the market with more than 50% share by 2024. The prophylaxis segment, on the other hand, is touted to grow at a robust rate due to easy availability of financial assistance programs and high need for better bleeding control.

Based on therapy, the hemophilia market is fragmented into replacement, gene, and immune tolerance induction therapies. The replacement therapy segment can enjoy a remarkable growth rate during the forecast period due to the launch of extended half-life versions of the existing drugs.

Regions covered in the market report include North America, Latin America (LATAM), Middle East & Africa (MEA), Asia-Pacific (APAC), and Europe. The North America market is expected to dominate over the forecast period on account of high prevalence of diseases and early adoption of prophylaxis treatment. In the 2013 survey conducted by the WFH, around 63% U.S. patients had adopted for prophylaxis. This high rate of adoption can continue driving the regional market in the forthcoming years.

The LATAM and APAC markets are anticipated to exhibit significant CAGRs respectively over the forecast period due to awareness regarding hemophilic diseases and rise in their prevalence. Availability of technologically advanced products, rise in R&D, and demand for plasma and recombinant derived products are also expected to bolster market growth over the forecast period.

Prominent players in the hemophilia market include Baxalta, Bayer Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., and Shire PLC. Developing additional products coupled with expansion plans in Middle Eastern and West African countries are strategies being considered by these players to increase their market share. Mergers, collaborations, and acquisitions are some of the strategies being considered by players to sustain their market hold. For instance, Biogen has partnered with the National Hemophilia Foundation (NHF), American Thrombosis and Hemostasis Network (ATHN), and Puget Sound Blood Center (PSBC) to launch a nation-wide program for free genetic testing of individuals and families ailing from blood-borne maladies.

Access Full Press Release Of This Report: www.grandviewresearch.com/press-release/global-hemophilia-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

The global  mHealth apps market  size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, In...